Loading clinical trials...
Loading clinical trials...
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Target PharmaSolutions, Inc.
NCT07439939 · Liver Cirrhosis, Portal Hypertension
NCT05899231 · Cirrhosis, Liver, Liver Transplant Surgery, and more
NCT05597488 · Cirrhosis Portal
NCT07480057 · Chronic Liver Disease and ACLF
NCT06680583 · Liver Cirrhosis, Gastrointestinal Bleeding
Keck School of Medicine of USC
Los Angeles, California
Stanford Medicine
Redwood City, California
Georgetown Medstar Transplant Institute
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions